Clinical trial
Topiramate in the Treatment of Pathological Gambling
NCT00245583 · Icahn School of Medicine at Mount Sinai, Other · Terminated
Key facts
| NCT number | NCT00245583 |
|---|---|
| Title | Topiramate in the Treatment of Pathological Gambling |
| Official title | Topiramate in the Treatment of Pathological Gambling: A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Study |
| Lead sponsor | Icahn School of Medicine at Mount Sinai, Other |
| Collaborators | Ortho-McNeil, Inc. Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pathological Gambling |
| Intervention type | Drug |
| Interventions | Topiramate, Placebo |
| Enrollment | 42 |
| Start date | Oct 1, 2005 |
| Primary completion | May 1, 2009 |
| Completion | May 1, 2009 |
| First posted | Oct 28, 2005 |
| Last update posted | Jul 2, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: